2022 Hospital Nuclear Medicine 
AuntMinnie
APRIL 15, 2024
Total nuclear medicine patient study volumes decreased by 5.7% decrease in hospital-based studies and a 2.5% decrease in total procedures each year, with hospital-based procedures declining by 5.5% and non-hospital procedures increasing by 1.2%. and non-hospital procedures increasing by 1.2%. Of these, 5.8
Imaging Technology
JUNE 27, 2023
Urbain, MD, PhD, FASNC , professor of radiology/nuclear medicine and medicine, vice chair of theranostics, and director of nuclear medicine at Roswell Park Cancer Center at the University of Buffalo , Buffalo, New York. and ‘How can we ensure diversity in all parts of the nuclear medicine family?’
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
MARCH 7, 2024
In 2023 compared with 2022, the total volume of positron emission tomography (PET) scans increased 10.2% from 1,401 estimated PET scans per system in 2022 to 1,495 in 2023. Davin Korstjens is a Senior Market Research Program Manager at IMV Medical Information Division, part of Science and Medicine Group.
AuntMinnie
JULY 1, 2024
of all imaging studies for Medicare fee-for-service beneficiaries in 2022, but that the remaining 27.9% The team conducted a study that included data from 123 million 2022 Medicare Part B imaging claims. for nuclear medicine 33.9% Nuclear medicine 11.8% Nuclear medicine 11.8% Of these, 88.5
AuntMinnie
JUNE 3, 2024
Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.
AuntMinnie
OCTOBER 25, 2024
Louis School of Medicine and completed his residency and a neuroradiology fellowship at Massachusetts General Hospital in Boston. Dempsey began working in radiography at Mercy Fitzgerald Hospital in Darby, Pennsylvania. She continued working at the hospital for 12 years while growing in her role as an educator.
AuntMinnie
OCTOBER 31, 2023
Fibroblast activation protein inhibitor (FAPI)-PET/CT appears superior to standard FDG-PET/CT for detecting gastrointestinal cancer, with higher radiotracer uptake seen in most tumors, according to a study published October 26 in the Journal of Nuclear Medicine. Image courtesy of the Journal of Nuclear Medicine.
Expert insights. Personalized for you.
111 
Let's personalize your content